Phase II study of camtobell inj. (belotecan) in combination with cisplatin in patients with previously untreated, extensive stage small cell lung cancer.
about
Belotecan/cisplatin versus etoposide/cisplatin in previously untreated patients with extensive-stage small cell lung carcinoma: a multi-center randomized phase III trial.Pei regimen: a therapeutic option in small cell lung cancer? A retrospective monoinstitutional analysis of 46 consecutive casesChemotherapy advances in small-cell lung cancerTherapies in the pipeline for small-cell lung cancer.Camptothecin (CPT) and its derivatives are known to target topoisomerase I (Top1) as their mechanism of action: did we miss something in CPT analogue molecular targets for treating human disease such as cancer?
P2860
Phase II study of camtobell inj. (belotecan) in combination with cisplatin in patients with previously untreated, extensive stage small cell lung cancer.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Phase II study of camtobell in ...... stage small cell lung cancer.
@ast
Phase II study of camtobell in ...... stage small cell lung cancer.
@en
type
label
Phase II study of camtobell in ...... stage small cell lung cancer.
@ast
Phase II study of camtobell in ...... stage small cell lung cancer.
@en
prefLabel
Phase II study of camtobell in ...... stage small cell lung cancer.
@ast
Phase II study of camtobell in ...... stage small cell lung cancer.
@en
P2093
P50
P1433
P1476
Phase II study of camtobell in ...... stage small cell lung cancer.
@en
P2093
Byoung Chul Cho
Eun Young Kim
Gun Min Kim
Hye Ryun Kim
Ji Soo Park
Joo Hang Kim
Joon Chang
Jun Ho Lee
Se Hyun Kim
P304
P356
10.1016/J.LUNGCAN.2013.02.009
P577
2013-03-16T00:00:00Z